This study looks at how well and how safe brenipatide works for adults with schizophrenia. Schizophrenia is a mental disorder affecting how a person thinks, feels, and behaves. The study compares brenipatide plus standard care (SoC) against a placebo (a "fake" treatment) plus SoC.
The study lasts up to 15 months and is divided into three parts: a 1-month screening period, a treatment period that can last up to 12 months, and a 2-month follow-up period. Participants must have a reliable partner, such as a family member or healthcare worker, to help them during the study.
Key Points:- The study could last up to 15 months, requiring regular visits and active participation.
- Participants must be willing to self-inject the study medication and complete diaries and questionnaires.
- Certain health conditions, like diabetes or substance abuse, disqualify participation.
How understandable was the trial content above?
Hard to understand
Easy to understand